NASDAQ:NDRA ENDRA Life Sciences (NDRA) Stock Price, News & Analysis $6.04 0.00 (0.00%) Closing price 09/25/2026 04:00 PM EasternExtended Trading$6.17 +0.13 (+2.20%) As of 09/25/2026 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsInsider TradesNews and TrendsOwnershipSEC Filings About ENDRA Life Sciences Stock (NASDAQ:NDRA) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get ENDRA Life Sciences alerts:Sign Up Key Stats Today's Range$5.84▼$6.3250-Day Range$4.16▼$6.5052-Week Range$2.96▼$9.85Volume37,386 shsAverage Volume63,307 shsMarket Capitalization$9.06 millionP/E RatioN/ADividend YieldN/APrice Target$25.00Consensus RatingHold Company Overview ENDRA Life Sciences Inc. is a medical technology company developing noninvasive imaging solutions for the assessment of tissue properties. Its technology is designed to expand the capabilities of conventional ultrasound systems by providing quantitative information that may support the detection and monitoring of disease. The company’s lead platform, TAEUS (Thermo-Acoustic Enhanced UltraSound), is being developed initially for the evaluation of liver fat associated with metabolic dysfunction-associated steatotic liver disease and related conditions. TAEUS is intended to work with existing ultrasound equipment, potentially offering clinicians a more accessible alternative to certain specialized imaging procedures. ENDRA Life Sciences is headquartered in Ann Arbor, Michigan, and its technology is under development and subject to regulatory review. The company’s primary focus is advancing TAEUS toward clinical use in liver imaging and exploring additional applications for its thermo-acoustic imaging approach.AI Generated. May Contain Errors. Read More ENDRA Life Sciences Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks61st Percentile Overall ScoreNDRA MarketRank™: ENDRA Life Sciences scored higher than 61% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.2 / 5Analyst RatingHold Consensus RatingENDRA Life Sciences has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and 1 sell rating.Upside PotentialENDRA Life Sciences has a consensus price target of $25.00, representing about 313.9% upside from its current price of $6.04.Amount of Analyst CoverageENDRA Life Sciences has only been the subject of 1 research reports in the past 90 days.Read more about ENDRA Life Sciences' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for ENDRA Life Sciences are expected to grow in the coming year, from ($4.11) to ($3.04) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of ENDRA Life Sciences is -0.95, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of ENDRA Life Sciences is -0.95, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioENDRA Life Sciences has a P/B Ratio of 3.15. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about ENDRA Life Sciences' valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.32% of the float of ENDRA Life Sciences has been sold short.Short Interest Ratio / Days to CoverENDRA Life Sciences has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in ENDRA Life Sciences has recently decreased by 0.87%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldENDRA Life Sciences does not currently pay a dividend.Dividend GrowthENDRA Life Sciences does not have a long track record of dividend growth. News and Social Media4.2 / 5News SentimentN/A News SentimentENDRA Life Sciences has a news sentiment score of 1.79. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.74 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 1 news article for ENDRA Life Sciences this week, compared to 2 articles on an average week.Search Interest2 people have searched for NDRA on MarketBeat in the last 30 days. MarketBeat Follows2 people have added ENDRA Life Sciences to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company Ownership0.4 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, ENDRA Life Sciences insiders have not sold or bought any company stock.Percentage Held by Insiders10.00% of the stock of ENDRA Life Sciences is held by insiders.Percentage Held by Institutions1.19% of the stock of ENDRA Life Sciences is held by institutions.Read more about ENDRA Life Sciences' insider trading history. Receive NDRA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ENDRA Life Sciences and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NDRA Stock News HeadlinesENDRA Shares Rise 12% As Q2 Loss Swings To Profit; Advances Noble Africa MergerSeptember 4, 2026 | rttnews.comENDRA Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business UpdateAugust 17, 2026 | finance.yahoo.comHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required.September 28 at 1:00 AM | Stansberry Research (Ad)ASP Isotopes to Host Investor Meetings at Citi’s 2026 Natural Resources ConferenceAugust 5, 2026 | quiverquant.comQASP Isotopes Announces Capital Markets Day in London on September 8, 2026July 28, 2026 | quiverquant.comQENDRA Life Sciences (NDRA) Gets a Buy from AscendiantJuly 25, 2026 | theglobeandmail.comENDRA Life Sciences Provides Update on U.S. Regulatory Strategy for its TAEUS ® SystemJuly 11, 2026 | businesswire.comHalper Sadeh LLC is Investigating Whether BOLD and NDRA are Obtaining Fair Deals for their ShareholdersJuly 2, 2026 | globenewswire.comSee More Headlines NDRA Stock Analysis - Frequently Asked Questions How have NDRA shares performed this year? ENDRA Life Sciences' stock was trading at $4.53 on January 1st, 2026. Since then, NDRA shares have increased by 33.3% and is now trading at $6.04. How were ENDRA Life Sciences' earnings last quarter? ENDRA Life Sciences Inc. (NASDAQ:NDRA) issued its earnings results on Friday, August, 14th. The company reported ($0.63) earnings per share for the quarter, topping the consensus estimate of ($0.84) by $0.21. When did ENDRA Life Sciences' stock split? ENDRA Life Sciences's stock reverse split on the morning of Tuesday, August 20th 2024.The 1-50 reverse split was announced on Friday, August 16th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Monday, August 19th 2024. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split. When did ENDRA Life Sciences IPO? ENDRA Life Sciences (NDRA) raised $10 million in an initial public offering on Friday, February 3rd 2017. The company issued 2,000,000 shares at $5.00-$5.50 per share. Dougherty & Company and Dawson James Securities acted as the underwriters for the IPO. Who are ENDRA Life Sciences' major shareholders? ENDRA Life Sciences' top institutional investors include Citizens Financial Group Inc. RI (2.24%). View institutional ownership trends. How do I buy shares of ENDRA Life Sciences? Shares of NDRA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of ENDRA Life Sciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that ENDRA Life Sciences investors own include Bionano Genomics (BNGO), Cocrystal Pharma (COCP), AMC Entertainment (AMC), Plug Power (PLUG), Mustang Bio (MBIO), SNDL (SNDL) and BIOLASE (BIOL). Company Calendar Last Earnings8/14/2026Today9/28/2026Next Earnings (Estimated)11/13/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (6m+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 NDRA's financial health is in the Green zone, according to TradeSmith. NDRA has been in this zone for over 6 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:NDRA CIK1681682 Webwww.endrainc.com Phone(734) 335-0468FaxN/AEmployees11Year FoundedN/APrice Target and Rating Average Price Target for ENDRA Life Sciences$25.00 High Price Target$25.00 Low Price Target$25.00 Potential Upside/Downside+313.9%Consensus RatingHold Rating Score (0-4)2.00 Research Coverage2 Analysts Profitability EPS (Trailing Twelve Months)($6.38) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$7.03 million Net MarginsN/A Pretax MarginN/A Return on Equity-246.34% Return on Assets-150.81% Debt Debt-to-Equity RatioN/A Current Ratio7.10 Quick Ratio7.10 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$1.92 per share Price / Book3.15Miscellaneous Outstanding Shares1,500,000Free Float1,350,000Market Cap$9.06 million OptionableNot Optionable Beta-0.05 (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free Report This page (NASDAQ:NDRA) was last updated on 9/28/2026 by MarketBeat.com Staff. From Our PartnersA Little Known Explorer Sits Near Major Gold DepositsBarrick Mining has spent decades building one of the world's great gold districts in Nevada, anchored by Fourm...Wall Street Logic | SponsoredUnder $5, Is This Nasdaq Early to America's Next Defense Boom?Small drones costing hundreds of dollars can now rival tanks and equipment worth millions, a shift Ukraine has...i2i Marketing Group, LLC | SponsoredThe Department of War is on a gold mine's filingsOn May 21, 2026, a federal bank board unanimously approved a nearly $3 billion loan to build a gold mine on Am...Behind the Markets | SponsoredMusk says UBI is coming. I say it's already here.Elon Musk says AI could make money irrelevant by 2036. One income program already exists today, funded not by ...Freedom Financial | SponsoredBuffett's Final Warning: "The Dollar Is Going to Hell"On May 3rd, 2025, Warren Buffett looked at his shareholders for the last time and said: "The dollar is going t...Decentralized Masters | SponsoredThis AI Stock Reminds One Analyst of Early NvidiaJeff Brown picked Nvidia in 2016, before shares surged 37,800 percent. Now he's identified another AI company ...Brownstone Research | SponsoredTrump's Monetary Reset Will Have a Right Side and a Wrong SideThe US Treasury still values its gold at $42 an ounce, a price set by Congress in 1973 and never updated. Gold...Monetary Gold | SponsoredA “bloodbath” Is ComingReports suggest some Silicon Valley billionaires are stockpiling gold, guns, and gas masks - or leaving the co...TradeSmith | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ENDRA Life Sciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ENDRA Life Sciences With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
